Listed by the USPTO as HOFFMAN, ALEXANDER JOSEPH
Tech Center 1700 • Art Units: 1600 1677 1798
This examiner grants 0% of resolved cases
HOFFMAN, ALEXANDER JOSEPH is a USPTO patent examiner in Tech Center 1700 and art unit 1600. The record contains 1 resolved case, with a 0.0% allowance rate, a 0.0% interview lift, and a median of 1134 days to allowance. Because the record contains only one resolved case, these outcome measures provide very limited evidence for predicting future prosecution results.
The listed companies are Abbott Laboratories, Genentech Inc., and University of Rochester. The associated firms are MARSHALL, GERSTEIN & BORUN LLP, CASIMIR JONES, S.C, and Clark+Elbing LLP - Genentech and Roche. Practitioners should treat the profile primarily as a matter and representation reference, not as a developed statistical benchmark.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18761632 | ASSAYS, CARTRIDGES, AND KITS FOR DETECTION OF BIOMARKERS, INCLUDING BRAIN INJURY BIOMARKERS | Non-Final OA | Abbott Point of Care Inc. |
| 18486325 | IN VITRO CELL-BASED ASSAY FOR PREDICTING PHARMACOKINETICS AND BRAIN PENETRATION OF BIOLOGICS | Non-Final OA | Genentech, Inc. |
| 18681988 | Nanomembrane Device And Method For Biomarker Sampling | Non-Final OA | University of Rochester |
| 18284993 | Laser-Based Fast Micromanufacturing of Test Device for Rapid Detection of Pathogens | Non-Final OA | Carnegie Mellon University |
| 18243349 | RAPID SCREENING METHODS FOR THYROID ASSOCIATED ORBITOPATHY | Final Rejection | The Chinese University of Hong Kong |
| 18708619 | PRODUCTS AND USES THEREOF FOR PREDICTING THE SENSITIVITY OF A SUBJECT TO CANCER IMMUNOTHERAPY AND FOR SELECTING OPTIMIZED THERAPY | Non-Final OA | UNIVERSITE PARIS-SACLAY |
| 18722357 | ASSAY METHOD USING MAGNETIC PARTICLES | Non-Final OA | HORIBA ABX SAS |
| 18618910 | CAPTURE REAGENT FOR LATERAL FLOW IMMUNOASSAY | Non-Final OA | IDEXX LABORATORIES, INC. |
| 18699169 | BIOMARKERS FOR DIAGNOSING TUBERCULOSIS | Non-Final OA | STELLENBOSCH UNIVERSITY |
| 18185164 | CXCL14 AS PREDICTIVE BIOMARKER FOR ACUTE LIVER FAILURE AND DEATH | Final Rejection | University of Kansas |
| 18835014 | SENESCENT CELL SURFACE MARKERS | Non-Final OA | SENS RESEARCH FOUNDATION |
| 18730462 | SYSTEM AND PROCESS FOR VISUALIZING TARGET MOLECULES | Non-Final OA | LIV PROCESS, INC. |
| 18741319 | DETECTION OF GLYCATED ALBUMIN IN DIABETES-AFFECTED BIOLOGICAL SAMPLES | Non-Final OA | InnSight Technology, Inc. |
| 18563723 | METHODS AND KITS FOR DIAGNOSING SYSTEMIC AUTOIMMUNE RHEUMATIC DISEASES | Non-Final OA | Université Laval |
| 18715567 | PROTEIN CORONA BIOMARKER ANALYSIS | Non-Final OA | THE ROYAL COLLEGE OF SURGEONS IN IRELAND |
| 18647791 | Method For Concentration And Avidity Detection Of Antibodies Against Immune System Related Diseases Measured With Evanescent Field Based Biosensors Using A Continuous Gradient Of Ligand Densities | Non-Final OA | VYSENS B.V. |
| 18704515 | ANTIBODIES TARGETING PHOSPHORYLATED SEVEN-TRANSMEMBRANE RECEPTORS | Non-Final OA | 7TM ANTIBODIES GMBH |
| 18693210 | Lung Cancer Prediction and Uses Thereof | Non-Final OA | SomaLogic Operating Co., Inc. |
| 18681198 | SYSTEMS AND METHODS FOR ANTIBODY CHAIN PAIRING | Non-Final OA | Rapid Novor Inc. |
| 18559281 | METHOD FOR THE PROGNOSIS OF PATIENTS SUFFERING FROM ATRIAL FIBRILLATION | Non-Final OA | SERVIZO GALEGO DE SAÚDE (SERGAS) |
| 17777988 | METHOD FOR EVALUATING SAFETY OF SUBSTANCE IN VITRO USING HUMAN IMMORTALIZED MYELOID CELLS | Final Rejection | Shimadzu Diagnostics Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy0.0% of resolved applications examined by Alexander Joseph Hoffman were allowed (1 resolved cases), compared with 37.3% across Art Unit 1600 over the last five years.
This examiner's interview lift is +0.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Alexander Joseph Hoffman took 1,134 days on average from filing to allowance.
Alexander Joseph Hoffman examines applications in Art Unit 1600 in Tech Center 1700 (Chemistry & Materials).
